The impact of Generative AI on the Efficiency and accuracy of drug discovery
Authors
Harsha Rajurkar
Department of Computer Science and Engineering M.S. Bidve Engineering College, Latur. (IN)
Article Information
DOI: 10.51583/IJLTEMAS.2026.150500225
Subject Category: Generative A
Volume/Issue: 15/5 | Page No: 2770-2774
Publication Timeline
Submitted: 2026-06-18
Published: 2026-06-18
Abstract
Drug discovery traditionally is a long and expensive process. It requires huge financial investment and can possibly take more than a decade to develop a single drug. In this paper, It has been explored how generative AI is changing this process. By using advanced models, generative AI can design new drug molecules, predict their properties, improve efficiency by reducing both time and cost required for research to get precise and accurate data. These models can generate drug candidates with better binding affinity and drug like properties, making the selection process more reliable. It is also being used across different stages of drug discovery, from identifying targets to monitoring drug safety. Although generative AI has great potential to transform drug discovery by making it faster, more efficient and accurate, there are still some challenges like the need for high quality data, lack of model transparency, regulatory concerns and more real world testing and comparison. These improvements are still needed for its full adoption.
Keywords
Generative AI, Drug Discovery, Molecular Design, Time Optimization, Cost Reduction, Predictive Modeling.
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Downloads
References
1. Kadan, A., Ryczko, K., Lloyd, E., Roitberg, A., & Yamazaki, T. (2025). Guided multi-objective generative AI to enhance structure-based drug design. In Chemical Science (Vol. 16, Issue 29, pp. 13196–13210). Royal Society of Chemistry (RSC). https://doi.org/10.1039/d5sc01778e [Google Scholar] [Crossref]
2. Obi, P., Gc, J. B., Mariasoosai, C., Diyaolu, A., & Natesan, S. (2024). Application of Generative Artificial Intelligence in Predicting Membrane Partitioning of Drugs: Combining Denoising Diffusion Probabilistic Models and MD Simulations Reduces the Computational Cost to One-Third. In Journal of Chemical Theory and Computation (Vol. 20, Issue 14, pp. 5866–5881). American Chemical Society (ACS). https://doi.org/10.1021/acs.jctc.4c00315 [Google Scholar] [Crossref]
3. Zhang, O., Lin, H., Zhang, H., Zhao, H., Huang, Y., Huang, Y., Jiang, D., Hsieh, C., Pan, P., & Hou, T. (2024). Deep Lead Optimization: Leveraging Generative AI for Structural Modification. Journal of the American Chemical Society. [Google Scholar] [Crossref]
4. Lai, L., Liu, Y., Song, B., Li, K., & Zeng, X. (2025). Deep Generative Models for Therapeutic Peptide Discovery: A Comprehensive Review. In ACM Computing Surveys (Vol. 57, Issue 6, pp. 1–29). Association for Computing Machinery (ACM). https://doi.org/10.1145/3714455 [Google Scholar] [Crossref]
5. Vora, D., Chan, A., Pangeni Pokharel, S., Liu, Q., Chen, R., Chen, B., Chen, A., Yang, L., & Chen, C.-W. (2025). CRISPR-tica.ai: A function-informed generative modeling pipeline for prioritizing drug discovery in AML. In Blood (Vol. 146, Issue Supplement 1, pp. 277–277). American Society of Hematology. https://doi.org/10.1182/blood-2025-277 [Google Scholar] [Crossref]
6. Bordukova, M., Makarov, N., Rodriguez-Esteban, R., Schmich, F., & Menden, M. P. (2023). Generative artificial intelligence empowers digital twins in drug discovery and clinical trials. In Expert Opinion on Drug Discovery (Vol. 19, Issue 1, pp. 33–42). Informa UK Limited. https://doi.org/10.1080/17460441.2023.2273839 [Google Scholar] [Crossref]
7. Vanier, A., Fernandez, J., Kelley, S., Alter, L., Semenzato, P., Alberti, C., Chevret, S., Costagliola, D., Cucherat, M., Falissard, B., Gueyffier, F., Lambert, J., Lengliné, E., Locher, C., Naudet, F., Porcher, R., Thiébaut, R., Vray, M., Zohar, S., … Le Guludec, D. (2023). Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health. In BMJ Evidence-Based Medicine (Vol. 29, Issue 1, pp. 1–5). BMJ. https://doi.org/10.1136/bmjebm-2022-112091 [Google Scholar] [Crossref]
8. Mishra, H. P., & Gupta, R. (2025). Leveraging Generative AI for Drug Safety and Pharmacovigilance. In Current Reviews in Clinical and Experimental Pharmacology (Vol. 20, Issue 2, pp. 89–97). Bentham Science Publishers Ltd. https://doi.org/10.2174/0127724328311400240823062829 [Google Scholar] [Crossref]
9. Abbas, M. K. G., Rassam, A., Karamshahi, F., Abunora, R., & Abouseada, M. (2024). The Role of AI in Drug Discovery. In ChemBioChem (Vol. 25, Issue 14). Wiley. https://doi.org/10.1002/cbic.202300816 [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- Block-Based Programming for Education: A Comprehensive Analysis of Visual Programming Environments in K-12 Learning
- Management of Academic Libraries and Client Satisfaction Towards Digital Utilization: Basis for Monitoring Library Operations in SOCCSKSARGEN Region.
- Revenue Leakages in TPA Insurance Claims and Corporate Claims: An Institutional Overview of Aster Prime Hospital, Hyderabad
- Technology and Innovation in Hospitality and Tourism: A Management Perspective
- Geospatial Distribution of Tarok Sacred Grove of Langtang North and Langtang South Local Government Areas